Novartis Warns on Profit as Heavy Investment in Entresto Weighs – Wall Street Journal

Novartis Warns on Profit as Heavy Investment in Entresto Weighs
Wall Street Journal
Swiss pharmaceutical giant Novartis AG NVS 0.53 % cautioned that its profit could fall this year due to heavy investment in its new heart-failure drug Entresto, after reporting a drop in net profit for the second quarter amid currency headwinds. The …
Novartis Second-Quarter Earnings, Revenue Fall Less Than ForecastTheStreet.com
Novartis says 2016 core operating profit may slipReuters
Novartis Says 2016 Profit May Drop on Entresto Costs, GleevecBloomberg
News On 6 –Financial Times –RTT News
all 10 news articles »